The Board of Directors of the Company at their meeting held on 24th March, 2026 has accepted the resignation of Mr. Indirakumar from the position of Whole-time Director of the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indrayani Biotech Ltd has informed BSE that its Board, at a meeting held on 24 March 2026, accepted the resignation of Mr. Singarababu Indirakumar (DIN: 00892351) from the position of Whole-time Director. The resignation took effect from the close of business hours on 24 March 2026, and the reason cited is 'professional reasons.' An internal email included in the filing reveals that Mr. Indirakumar claims he had already resigned on 16 March 2026 and had informed the Registrar of Companies, and he objected to receiving a fresh board meeting notice on 20 March 2026. The formal board acceptance came on 24 March 2026.
This is a senior leadership departure at a small-cap company, which may create short-term uncertainty around management continuity. Investors should watch for timely disclosure of a replacement WTD/CEO and any further clarifications on the circumstances of the exit.